BEAM - CIK 0001745999
Beam Therapeutics Inc. (BEAM) reported net income of -$79.99M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$79.99M | +78.8% |
| FY 2024 | -$376.74M | -184.3% |
| FY 2023 | -$132.53M | +54.2% |
| FY 2022 | -$289.09M | +22.0% |
| FY 2021 | -$370.68M | -90.5% |
| FY 2020 | -$194.59M | -148.4% |
| FY 2019 | -$78.33M | - |
Beam Therapeutics Inc. (BEAM) reported net income of -$79.99M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Beam Therapeutics Inc.'s net income declined from -$78.33M to -$79.99M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.